|
Demographic characteristics of MSM population
|
|
|
| Proportion of MSM among sexually active men (≥15 years old) |
1%-2% |
[26] |
| Population size of MSM in 2010 |
108,000 |
a
|
| Average life expectancy of HIV negative MSM |
79 years |
[27] |
| Sexually active life years of MSM |
46 years |
[26] |
|
CD4 based natural history of HIV infection with or without ART
|
|
|
| Length of acute HIV infection |
3 months |
[22–23] |
| Length of early latent infection |
4.33 years |
[29] |
| Length of late latent infection |
2.66 years |
[29] |
| Length of AIDS period |
2 years |
[22,24] |
| Life expectancy of PLWHA initiating ART at early latent infection stage |
79 years |
[30–32] |
| Life expectancy of PLWHA initiating ART at late latent infection stage |
33.7 years |
b
|
| Life expectancy of PLWHA initiating ART at AIDS stage |
22.2 years |
b
|
|
Treatment withdrawal or failure of HIV infected MSM
|
|
|
| Proportion of ART patients withdrawing or failing in treatment |
3%-7% |
c
|
|
Infectiousness of HIV infected MSM by disease stage
|
|
|
| Average number of people infected by a HIV positive MSM in a year |
0.12–0.13 |
d
|
| Acute infection |
1.2–1.3 |
|
| Early latent infection |
0.12–0.13 |
|
| Late latent infection |
0.24–0.26 |
|
| AIDS |
0.6–0.65 |
|
|
Transmission risk of HIV infected MSM on ART
|
|
|
| Relative risk of Transmission of HIV infected MSM on ART versus those not on ART |
0.04–0.1 |
[35] |
|
HIV testing rate and ART coverage
|
|
|
| HIV testing rate under current practice |
50% |
c
|
| HIV testing rate under test-and-treat strategy |
50%-90% |
|
| ART coverage under current practice |
39% |
c
|
| ART coverage under test-and-treat strategy |
39%-90% |
|
